Nayden Denis 4
4 · Accretive Health, Inc. · Filed Apr 4, 2012
Insider Transaction Report
Form 4
Nayden Denis
Director
Transactions
- Award
Director Stock Option (right to buy)
2012-04-02$9.82/sh+1,527$14,995→ 1,527 totalExercise: $20.00From: 2012-04-02Exp: 2022-04-02→ Common Stock (1,527 underlying)
Footnotes (1)
- [F1]This option was issued to the reporting person pursuant to the Accretive Health director compensation plan in lieu of retainer fees of $15,000.